Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
Balaji Veluswamy, Andy Lee, Rukhsana G Mirza, Manjot K Gill Northwestern University, Feinberg School of Medicine, Chicago, IL, USACorrespondence: Manjot K Gill Tel +1 312 908-8152Fax +1 312 503-8152Email mgill@nm.orgPurpose: Neovascular age-related macular degeneration (nv-AMD) is the leading cause...
Guardado en:
Autores principales: | Veluswamy B, Lee A, Mirza RG, Gill MK |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/be5a9a16595c4518966869507061af43 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Physician, patient, and caregiver experience of different wet age-related macular degeneration anti-VEGF treatment regimens in Japan: a qualitative assessment
por: Iida T, et al.
Publicado: (2016) -
Age, sex, and type of medication predict the effect of anti-VEGF treatment on central retinal thickness in wet age-related macular degeneration
por: Bek T, et al.
Publicado: (2018) -
Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
por: Koike N, et al.
Publicado: (2019) -
Predictors of Visual Acuity After Treatment of Neovascular Age-Related Macular Degeneration – Current Perspectives
por: Phan LT, et al.
Publicado: (2021) -
Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment
por: Pongsachareonnont P, et al.
Publicado: (2018)